Levin Capital Strategies’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-3,100
Closed -$372K 387
2021
Q4
$372K Buy
3,100
+1,100
+55% +$137K 0.03% 202
2021
Q3
$247K Buy
+2,000
New +$257K 0.02% 257
2015
Q4
Sell
-8,500
Closed -$279K 381
2015
Q3
$279K Sell
8,500
-951,458
-99% -$32M ﹤0.01% 314
2015
Q2
$35.6M Sell
959,958
-55,285
-5% -$2.01M 0.53% 47
2015
Q1
$35.6M Buy
1,015,243
+1,004,246
+9,132% +$35.4M 0.53% 45
2014
Q4
$419K Buy
+10,997
New +$402K 0.01% 297

Other funds holding XYL

Levin Capital Strategies's XYL Position: Q1 2022 in Review

Levin Capital Strategies sold out of Xylem (XYL) in Q1 2022, closing a stake of 3,100 shares — an estimated $372K sold.

Levin Capital Strategies first reported a position in XYL in Q4 2014 and held it in 6 quarters. The position peaked at $35.6M in Q2 2015. 759 funds tracked by Wall St. Rank hold XYL as of Q1 2022.

  • Levin Capital Strategies reported no remaining Xylem position as of Q1 2022 after selling out during the quarter.
  • Levin Capital Strategies sold 3,100 Xylem shares in Q1 2022, an estimated $372K.
  • Levin Capital Strategies first reported a position in Xylem in Q4 2014 and held it in 6 quarters.
  • Levin Capital Strategies's Xylem position peaked at $35.6M in Q2 2015.
  • 759 funds tracked by Wall St. Rank held Xylem as of Q1 2022.

Based on Levin Capital Strategies's 13F filing for Q1 2022, filed 2 May 2022.